|
|
 |
|
Viewing report
|
|
|
|
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
GlobalData, March 2012, Pages: 208
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
Summary
Abbott Laboratories (Abbott) is a global healthcare company. It undertakes the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products along with pharmaceuticals, diagnostics, vascular and nutritional products. The company’s diverse family of pharmaceutical, medical, and nutritional products includes a wide range of specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; a range of nutritional supplements for infants, children and adults; and products for veterinary care. Its research and development, manufacturing and administrative facilities are located in more than 100 countries worldwide.
Abbott envisages building its position in the marketplace through new product launches, network expansion, internal development, in-licensing of technology and products, acquisitions and strategic alliances. The company markets its products through its own sales offices and distributors in over 130 countries globally. Abbott is headquartered in Abbott Park, Illinois, the US.
Abbott Laboratories Key Recent Developments
Mar 21, 2012: Abbott Selects AbbVie As New Name For Future Research-Based Pharmaceutical Company
Mar 20, 2012: Abbott Announces Its Schedule Of Key Presentations To Be Held At ACC 2012, Chicago
Mar 01, 2012: Abbott To Build Nutrition Manufacturing Facility In Ohio
Jan 25, 2012: Abbott Reports Net Sales Of $10.4 Billion In Q4 2011
Dec 19, 2011: Abbott And University Of Illinois Establish Center For Nutrition, Learning And Memory
This comprehensive SWOT profile of Abbott Laboratories provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review
Alexza Pharmaceuticals, Inc. (ALXA) - Financial and Strategic SWOT Analysis Review
Syneron Medical Ltd. (ELOS) - Financial and Strategic SWOT Analysis Review
Forest Laboratories, Inc. (FRX) - Financial and Strategic SWOT Analysis Review
Abbott Laboratories: PharmaVitae Profile
Life Technologies Corporation (LIFE) - Financial and Strategic SWOT Analysis Review
Covidien plc (COV) - Financial and Strategic SWOT Analysis Review
Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review
Cubist Pharmaceuticals, Inc. (CBST) - Financial and Strategic SWOT Analysis Review
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review
|
|
|
|
